Inovio Pharmaceuticals Inc (INO)

[Lakers_w]

@DeptofDefense please provide funds for @InovioPharma now! The DOD’s physical year begins 10/1/2020 so you must have budgeted for #INO_4800 ? You can’t come out and say you will fund them for phase 1 & 2. Show your support now! @inoviolt where is @CEPIvaccines funding?

This funding was the biggest catalyst that we were all waiting for to see the share price jump! Quite disappointed that they didn't announce an amount. I am thinking they need to announce it by year end for their expenses and book keeping.

Sir, the pentagon has already requested budget funds from Congress and it has been approved. The Government’s accounting physical year runs from 10/1/2020 to 9/30/2021 so we are just 45 into this budget year so, the money has to be there. It’s just a matter of when! @inoviolt

I am just saying Inovio has to do their expenses and book keeping for year end, so they need to disclose an amount.

True. Great point!

Any contract over 7 million has to be posted on the dod contract site.

Contracts valued at $7.5 million or more are announced each business day at 5 p.m.
https://www.defense.gov/Newsroom/Contracts/

Inovio Pharmaceuticals Inc.,* Plymouth Meeting, Pennsylvania, was awarded a $16,570,397 firm-fixed-price contract for 900 CELLECTRA 2000 DNA vaccine injection devices. Bids were solicited via the internet with one received. Work will be performed in Plymouth Meeting, Pennsylvania, with an estimated completion date of Dec. 31, 2020. Fiscal 2020 defense emergency response funds in the amount of $16,570,397 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W911QY-20-C-0084). (Awarded June 19, 2020)

https://www.defense.gov/Newsroom/Contracts/Contract/Article/2228273/

Ology Bioservices Inc.,* Alachua, Florida, was awarded a $106,300,002 firm-fixed-price contract to reserve production capacity of approximately 186,840,000 doses to satisfy an urgent need for domestic aseptic fill and finish manufacturing of critical vaccines and therapeutics in support of the Operation Warp Speed response to the COVID-19 pandemic. Bids were solicited via the internet with eight received. Work will be performed in Alachua, Florida, with an estimated completion date of Aug. 10, 2021. Reimbursable fiscal 2020 Army research, development, test and evaluation funds backed by the fiscal 2020 Public Health and Social Services Emergency Fund, Office of the Secretary, Health and Human Services, in the amount of $53,150,001 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W911QY-20-C-0101). (Awarded Aug. 17, 2020)

https://www.defense.gov/Newsroom/Contracts/Contract/Article/2317151/